AMN
AMN Healthcare Services, Inc.
Medical - Care Facilities
Market Cap$869M
5Y Perf.-49.3%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
AMN vs HCSG vs CCRN vs TBI
Revenue, margins, valuation, and 5-year total return — side by side.
HCSG
Healthcare Services Group, Inc.
Medical - Care Facilities
Market Cap$1.60B
5Y Perf.-6.7%
CCRN
Cross Country Healthcare, Inc.
Medical - Care Facilities
Market Cap$423M
5Y Perf.+115.7%
TBI
TrueBlue, Inc.
Staffing & Employment Services
Market Cap$182M
5Y Perf.-61.1%
AMN vs HCSG vs CCRN vs TBI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AMN | HCSG | CCRN | TBI |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Staffing & Employment Services |
| Market Cap | $869M | $1.60B | $423M | $182M |
| Revenue (TTM) | $3.42B | $1.84B | $761M | $1.25B |
| Net Income (TTM) | $-32M | $59M | $-99M | $-53M |
| Gross Margin | 25.5% | 13.3% | 18.2% | 28.4% |
| Operating Margin | 0.3% | 3.0% | -0.9% | -2.6% |
| Forward P/E | 11.0x | 20.8x | 133.8x | — |
| Total Debt | $803M | $25M | $2M | $171M |
| Cash & Equiv. | $34M | $161M | $109M | $25M |
AMN vs HCSG vs CCRN vs TBI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AMN
HCSG
CCRN
TBI
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 100 | 50.7 | -49.3% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| Cross Country Healt… (CCRN) | 100 | 215.7 | +115.7% |
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMN vs HCSG vs CCRN vs TBI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: HCSG leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. AMN Healthcare Services, Inc. is the stronger pick specifically for valuation and capital efficiency. CCRN also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AMN
AMN Healthcare Services, Inc.
The Value Play
AMN is the #2 pick in this set and the best alternative if value is your priority.
- Better valuation composite
Best for: value
HCSG
Healthcare Services Group, Inc.
The Growth Play
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs CCRN's -21.6%
- 3.2% margin vs CCRN's -13.0%
- +55.8% vs CCRN's -5.4%
Best for: growth exposure
CCRN
Cross Country Healthcare, Inc.
The Income Pick
CCRN is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.78
- -10.5% 10Y total return vs HCSG's -26.8%
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
- Beta 0.78, current ratio 3.78x
Best for: income & stability and long-term compounding
TBI
TrueBlue, Inc.
The Secondary Option
TBI lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: industrials exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | HCSG | 7.1% revenue growth vs CCRN's -21.6% |
| Value | AMN | Better valuation composite |
| Quality / Margins | HCSG | 3.2% margin vs CCRN's -13.0% |
| Stability / Safety | CCRN | Beta 0.78 vs TBI's 1.13, lower leverage |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | HCSG | +55.8% vs CCRN's -5.4% |
| Efficiency (ROA) | HCSG | 7.3% ROA vs CCRN's -19.8%, ROIC 9.0% vs -0.9% |
AMN vs HCSG vs CCRN vs TBI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2025
FY 2025
AMN vs HCSG vs CCRN vs TBI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLHCSGLAGGINGTBI
Who Leads Where
HCSG leads in 3 of 6 categories
AMN leads 2 • CCRN leads 0 • TBI leads 0 • 1 tied
Explore the data ↓TBITrueBlue, Inc.
0leads
CCRNCross Country Healthc…
0leads
AMNAMN Healthcare Servic…
2leads
HCSGHealthcare Services G…
3leads
6 Total Categories
CATEGORYLEADERvs AMNvs CCRNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMN3/6
Valuation MetricsMultiples, price ratios, and targets
AMN4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
HCSG7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
HCSG4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
HCSG1/1
Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMN is the larger business by revenue, generating $3.4B annually — 4.5x CCRN's $761M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.4B | $1.8B | $761M | $1.2B |
| EBITDAEarnings before interest/tax | $127M | $72M | $9M | -$10M |
| Net IncomeAfter-tax profit | -$32M | $59M | -$99M | -$53M |
| Free Cash FlowCash after capex | $714M | $139M | $41M | -$60M |
| Gross MarginGross profit ÷ Revenue | +25.5% | +13.3% | +18.2% | +28.4% |
| Operating MarginEBIT ÷ Revenue | +0.3% | +3.0% | -0.9% | -2.6% |
| Net MarginNet income ÷ Revenue | -0.9% | +3.2% | -13.0% | -4.3% |
| FCF MarginFCF ÷ Revenue | +20.9% | +7.6% | +5.4% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +99.9% | +6.6% | -100.0% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.8% | +175.0% | -6.0% | -37.5% |
AMN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
AMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| Market CapShares × price | $869M | $1.6B | $423M | $182M |
| Enterprise ValueMkt cap + debt − cash | $1.6B | $1.5B | $317M | $329M |
| Trailing P/EPrice ÷ TTM EPS | -9.06x | 27.54x | -4.47x | -3.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.05x | 20.83x | 133.84x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.63x | 22.38x | 23.75x | 160.03x |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 0.87x | 0.40x | 0.11x |
| Price / BookPrice ÷ Book value/share | 1.35x | 3.19x | 1.31x | 0.65x |
| Price / FCFMarket cap ÷ FCF | 3.72x | 11.49x | 10.55x | — |
AMN leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
HCSG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs TBI's 4/9, reflecting strong financial health.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.0% | +11.8% | -27.1% | -18.7% |
| ROA (TTM)Return on assets | -1.4% | +7.3% | -19.8% | -8.1% |
| ROICReturn on invested capital | +1.6% | +9.0% | -0.9% | -5.2% |
| ROCEReturn on capital employed | +2.0% | +7.7% | -0.8% | -5.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.25x | 0.05x | 0.01x | 0.62x |
| Net DebtTotal debt minus cash | $769M | -$136M | -$106M | $146M |
| Cash & Equiv.Liquid assets | $34M | $161M | $109M | $25M |
| Total DebtShort + long-term debt | $803M | $25M | $2M | $171M |
| Interest CoverageEBIT ÷ Interest expense | -1.70x | 33.02x | -1.39x | -46.19x |
HCSG leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, HCSG leads with a +55.8% total return vs CCRN's -5.4%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +48.7% | +28.6% | +62.4% | +36.6% |
| 1-Year ReturnPast 12 months | +14.6% | +55.8% | -5.4% | +51.0% |
| 3-Year ReturnCumulative with dividends | -75.1% | +48.6% | -44.3% | -60.2% |
| 5-Year ReturnCumulative with dividends | -75.1% | -21.1% | -22.5% | -78.7% |
| 10-Year ReturnCumulative with dividends | -41.5% | -26.8% | -10.5% | -68.4% |
| CAGR (3Y)Annualised 3-year return | -37.1% | +14.1% | -17.7% | -26.4% |
HCSG leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — AMN and CCRN each lead in 1 of 2 comparable metrics.
Risk & Volatility
CCRN is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs TBI's 77.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 1.12x | 0.78x | 1.13x |
| 52-Week HighHighest price in past year | $23.74 | $24.39 | $14.99 | $7.78 |
| 52-Week LowLowest price in past year | $14.87 | $12.66 | $7.43 | $3.18 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +91.5% | +87.3% | +77.2% |
| RSI (14)Momentum oscillator 0–100 | 57.2 | 61.8 | 53.1 | 83.2 |
| Avg Volume (50D)Average daily shares traded | 849K | 676K | 552K | 386K |
Evenly matched — AMN and CCRN each lead in 1 of 2 comparable metrics.
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AMN as "Buy", HCSG as "Hold", CCRN as "Hold", TBI as "Buy". Consensus price targets imply 9.8% upside for HCSG (target: $25) vs -18.9% for CCRN (target: $11).
| Metric | AMNAMN Healthcare Se… | HCSGHealthcare Servic… | CCRNCross Country Hea… | TBITrueBlue, Inc. |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $22.50 | $24.50 | $10.61 | $5.75 |
| # AnalystsCovering analysts | 17 | 15 | 14 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 20 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +3.9% | +1.6% | +0.6% |
HCSG leads this category, winning 1 of 1 comparable metric.
Key Takeaway
HCSG leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). AMN leads in 2 (Income & Cash Flow, Valuation Metrics). 1 tied.
Best OverallHealthcare Services Group, … (HCSG)Leads 3 of 6 categories
Loading custom metrics...
AMN vs HCSG vs CCRN vs TBI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMN or HCSG or CCRN or TBI a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMN or HCSG or CCRN or TBI?
On forward P/E, AMN Healthcare Services, Inc.
is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AMN or HCSG or CCRN or TBI?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 1%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: CCRN returned -10. 5% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMN or HCSG or CCRN or TBI?
By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.
(CCRN) is the lower-risk stock at 0. 78β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 46% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMN or HCSG or CCRN or TBI?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMN or HCSG or CCRN or TBI?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -1. 7% for TBI. At the gross margin level — before operating expenses — AMN leads at 22. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMN or HCSG or CCRN or TBI more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc.
(AMN) trades at 11. 0x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 122. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCSG: 9. 8% to $24. 50.
08Which pays a better dividend — AMN or HCSG or CCRN or TBI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AMN or HCSG or CCRN or TBI better for a retirement portfolio?
For long-horizon retirement investors, Cross Country Healthcare, Inc.
(CCRN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 78)). Both have compounded well over 10 years (CCRN: -10. 5%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMN and HCSG and CCRN and TBI?
These companies operate in different sectors (AMN (Healthcare) and HCSG (Healthcare) and CCRN (Healthcare) and TBI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(AMN: 99.9% · HCSG: 6.6%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.